Document is current
Any future updates will be listed below
-
Authors
Zhao, Gaoxiang https://orcid.org/0000-0001-5284-7228
Luo, Shudi
Zhao, Hong
Ma, Qingxia
Jiang, Hongfei https://orcid.org/0000-0001-5869-5253
Wang, Lin
Liu, Juanjuan
Guo, Dong https://orcid.org/0000-0001-7057-2838
Wang, Runze
Xu, Qianqian
Lun, Jie
Xie, Ranran
Duan, Yixin
Ma, Leina https://orcid.org/0000-0003-3964-632X
Qiu, Wensheng https://orcid.org/0000-0002-4293-9193
Fang, Jing https://orcid.org/0000-0002-4106-5703
Lu, Zhimin https://orcid.org/0000-0002-2859-2736
- License Information
-
More Information
Article History
Received: 27 February 2025
Accepted: 23 July 2025
First Online: 4 August 2025
Competing interests
: Z.L. owns shares in Signalway Biotechnology (Pearland, TX), which supplied the rabbit antibodies that recognize GCK pS398 and TAZ pT346. Z.L.’s interest in this company had no bearing on its being chosen to supply these reagents. The remaining authors declare no competing interests.
